Sorafenib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00398 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | liposarcoma | KG + DL |
| 2 | ovarian myxoid liposarcoma | KG + DL |
| 3 | unclassified renal cell carcinoma | KG + DL |
| 4 | renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions | KG + DL |
| 5 | renal cell carcinoma associated with neuroblastoma | KG + DL |
| 6 | childhood kidney cell carcinoma | KG + DL |
| 7 | female breast carcinoma | KG + DL |
| 8 | renal pelvis carcinoma | KG + DL |
| 9 | vulva sarcoma | KG + DL |
| 10 | dermatofibrosarcoma protuberans | KG + DL |
| 11 | angiolipoma | KG + DL |
| 12 | renal carcinoma | KG + DL |
| 13 | spindle cell liposarcoma | KG + DL |
| 14 | heart fibrosarcoma | KG + DL |
| 15 | fibroblastic neoplasm | KG + DL |
| 16 | kidney fibrosarcoma | KG + DL |
| 17 | childhood malignant neoplasm | KG + DL |
| 18 | conventional fibrosarcoma | KG + DL |
| 19 | low grade fibromyxoid sarcoma | KG + DL |
| 20 | familial spontaneous pneumothorax | KG + DL |
| 21 | endocrine-cerebro-osteodysplasia syndrome | KG + DL |
| 22 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 23 | liver fibrosarcoma | KG + DL |
| 24 | collecting duct carcinoma | KG + DL |
| 25 | bone fibrosarcoma | KG + DL |
| 26 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 27 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 28 | rhabdomyosarcoma (disease) | KG + DL |
| 29 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 30 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 31 | liver sarcoma | KG + DL |
| 32 | chromophobe renal cell carcinoma | KG + DL |
| 33 | mixed endometrial stromal and smooth muscle tumor | KG + DL |
| 34 | sarcomatoid renal cell carcinoma | KG + DL |
| 35 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 36 | leiomyosarcoma | KG + DL |
| 37 | anus leiomyosarcoma | KG + DL |
| 38 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
| 39 | estrogen-receptor negative breast cancer | KG + DL |
| 40 | small intestinal sarcoma | KG + DL |
| 41 | familial rhabdoid tumor | KG + DL |
| 42 | hormone-resistant breast carcinoma | KG + DL |
| 43 | estrogen-receptor positive breast cancer | KG + DL |
| 44 | Ehrlich tumor carcinoma | KG + DL |
| 45 | retroperitoneal sarcoma | KG + DL |
| 46 | cutaneous leiomyosarcoma (disease) | KG + DL |
| 47 | sclerosing liposarcoma | KG + DL |
| 48 | paroxysmal dyskinesia | KG + DL |
| 49 | cutaneous undifferentiated pleomorphic sarcoma | KG + DL |
| 50 | bilateral breast carcinoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.